General Information of the Compound
| Compound ID |
CP0919122
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S)-1-(benzo[d][1,3]dioxol-5-ylmethyl)-3-((S)-3-(biphenyl-4-yl)-2-(3-(4-(ethoxycarbonyl)phenyl)ureido)propanamido)-1-methylpyrrolidinium
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H41IN4O6
|
||||||||||||||||||
| Molecular Weight |
776.672
|
||||||||||||||||||
| Canonical SMILES |
CCOC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(-c3ccccc3)cc2)C(=O)N[C@H]2CC[N+](C)(Cc3ccc4c(c3)OCO4)C2)cc1.[I-]
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H40N4O6.HI/c1-3-46-37(44)30-14-16-31(17-15-30)40-38(45)41-33(21-26-9-12-29(13-10-26)28-7-5-4-6-8-28)36(43)39-32-19-20-42(2,24-32)23-27-11-18-34-35(22-27)48-25-47-34;/h4-18,22,32-33H,3,19-21,23-25H2,1-2H3,(H2-,39,40,41,43,44,45);1H/t32-,33-,42?;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
TZMFISJHWGELJA-HUXLDHJRSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Protein ID: PT01198, Muscarinic acetylcholine receptor M2
Protein ID: PT01266, Muscarinic acetylcholine receptor M3